- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/04 - Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
Patent holdings for IPC class A61P 5/04
Total number of patents in this class: 45
10-year publication summary
|
2
|
3
|
3
|
3
|
1
|
4
|
2
|
3
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Kissei Pharmaceutical Co., Ltd. | 178 |
4 |
| Bayer Intellectual Property GmbH | 2356 |
2 |
| Bayer Pharma AG | 1009 |
2 |
| Aeterna Zentaris GmbH | 38 |
2 |
| Endorecherche, Inc. | 21 |
2 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 173 |
2 |
| Jiangsu Hengrui Medicine Co., Ltd. | 685 |
2 |
| Oakwood Laboratories, LLC | 49 |
2 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 718 |
2 |
| University of Saskatchewan | 488 |
2 |
| Novartis AG | 10175 |
1 |
| Glaxosmithkline LLC | 526 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6697 |
1 |
| Wisconsin Alumni Research Foundation | 3903 |
1 |
| Beijing Neurosurgical Institute | 34 |
1 |
| Ferring B.V. | 710 |
1 |
| Maatschap Interne Geneeskunde Rijnstate | 1 |
1 |
| Monash University | 732 |
1 |
| Nippon Chemiphar Co., Ltd. | 225 |
1 |
| Other owners | 12 |